文献速递乳腺乳腺X线

低剂量光子计数数字乳腺断层摄影与市售断层摄影单元在乳腺癌检测与表征中的比较

Low dose photon-counting digital breast tomosynthesis: comparison with a commercially available tomosynthesis unit in the detection and characterization of breast carcinomas.
PubMed 文献 · Radiol Med · 2025-10-04

这项初步前瞻性研究纳入17例BI-RADS 4c/5可疑乳腺病灶女性,在活检前分别用常规数字乳腺断层摄影(DBT)和光子计数DBT原型机行双侧两视角DBT,比较图像质量和平均腺体剂量(AGD),以组织学为参考标准。结果显示两种系统密度和BI-RADS评分无显著差异,光子计数DBT在94%的观察中病灶清晰度等于或优于常规DBT,其平均AGD较常规DBT降低55%。作者结论为根据这些初步数据,光子计数DBT提供与常规DBT单元相似的高图像质量,同时大幅降低AGD。

要点

  • 光子计数DBT平均腺体剂量较常规DBT降低55%。
  • 94%的观察中光子计数DBT病灶清晰度等于或优于常规DBT。
  • 两种系统密度和BI-RADS评分无显著差异。

核心结论

  • 根据这些初步数据,光子计数DBT提供与常规DBT单元相似的高图像质量,同时大幅降低所交付的平均腺体剂量。

研究设计与样本

  • 初步前瞻性研究,纳入17例有可疑乳腺病灶(BI-RADS 4c/5)的女性,活检前分别用常规DBT单元和光子计数原型机行双侧两视角DBT,以影像引导空心针活检组织学为标准参考。

关键影像表现/征象

  • 15例检查中两种系统均可检出至少一个可疑病灶。
  • 2例检查因高密度和小癌灶尺寸在两种设备上均为假阴性。
  • 所有可疑病灶经组织学证实为恶性。

诊断标准与关键数值

  • 光子计数DBT的平均AGD较常规DBT降低55%。
  • 病灶清晰度在94%的观察中评为光子计数DBT等于或优于常规DBT。
  • 两种系统间密度和BI-RADS评分无显著差异。

局限性

  • 原文为初步研究,样本量为17例。
  • 原文结论称根据这些初步数据,提示需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Digital Breast Tomosynthesis (DBT) has a diagnostic accuracy higher than 2D-FFDM, with a slightly higher Average Glandular Dose (AGD). Photon-counting technology was demonstrated to reduce AGD of 2D-FFDM, while preserving a high image quality; it therefore represents an interesting solution to significantly reduce the radiation dose of DBT. Our purpose is to compare the image quality and the AGD of a photon-counting DBT prototype with a conventional DBT unit in the detection of breast carcinoma.

MATERIALS AND METHODS: In this preliminary prospective study, 17 women with a suspicious breast finding (BI-RADS 4c/5) were enrolled. Before biopsy, they underwent bilateral 2-view DBT with a conventional unit and a photon-counting prototype. The AGD delivered by the two DBT units were compared. Three readers independently reviewed and compared the images (DBT and synthesized 2D) giving a density, BI-RADS and conspicuity score focusing on suspicious findings. All women underwent core-needle biopsy with imaging guidance and histology was used as standard reference.

RESULTS: In 15 examinations at least one suspicious finding was detectable by both systems. Two exams were falsely negative with both units due to high density and small cancer size. All suspicious findings were histologically confirmed as malignant. There was no significant difference in density and BI-RADS scores. The conspicuity of findings was scored as equal or better for photon-counting DBT in 94% observations. The mean AGD delivered by photon-counting DBT was 55% lower than the conventional DBT.

CONCLUSION: According to these preliminary data, photon-counting DBT provides a high image quality, like a conventional DBT unit, with a drastic reduction of the AGD delivered.

TRIAL REGISTRATION NUMBER: The clinical trial "Low Dose Tomosynthesis Compared to Traditional Tomosynthesis" has an identifier number NCT02771444 on the ClinicalTrials.gov website. It was first registered on 11.05.2016.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Venturini E, Losio C, Rodighiero M, et al. Low dose photon-counting digital breast tomosynthesis: comparison with a commercially available tomosynthesis unit in the detection and characterization of breast carcinomas. Radiol Med. 2025. PMID: 41045355. doi:10.1007/s11547-025-02115-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。